sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Asia Pacific Anticoagulant Reversal Drug Market Scope And Analysis

  • Report Code : TIPRE00022193
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 149
Buy Now

Asia Pacific Anticoagulant Reversal Drug Market Analysis, Scope, and Growth by 2027

Buy Now

Asia Pacific Anticoagulant Reversal Drug Market Report Asia Pacific Anticoagulant Reversal Drug Market Size and Share Asia Pacific Anticoagulant Reversal Drug Market Scope and Analysis

Asia Pacific Anticoagulant Reversal Drug Market Report Scope

Report Attribute Details
Market size in 2019 US$ 173.5 Million
Market Size by 2027 US$ 444.8 Million
Global CAGR (2019 - 2027) 13.2%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Product
  • Prothrombin Complex Concentrates
  • Vitamin K
  • Protamine
  • Tranexamic Acid
  • Idarucizumab
  • AndeXXa
By End User
  • Hospital Pharmacies
  • Retail Pharmacies
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • Boehringer Ingelheim International GmbH
  • Pfizer Inc
  • Octapharma AG
  • Fresenius Kabi AG
  • Alexion Pharmaceuticals Inc Portola Pharmaceuticals
  • CSL Limited
  • Grifols S A
  • China Biologic Products Inc
  • Shanghai RAAS Blood Products Co Ltd